Terms: = Lymphoma AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1 AND Treatment
13 results:
1. [Pathogenesis and Targeted treatment Progress of Splenomegaly in Primary Myelofibrosis--Review].
Chen ZW; Wang SX; Li F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):308-312. PubMed ID: 38387940
[TBL] [Abstract] [Full Text] [Related]
2. Conteltinib (CT-707) in patients with advanced ALK-positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study.
Xing P; Zhao Q; Zhang L; Wang H; Huang D; Hu P; Sun Y; Shi Y
BMC Med; 2022 Nov; 20(1):453. PubMed ID: 36424628
[TBL] [Abstract] [Full Text] [Related]
3. [treatment strategy for myeloid leukemia with Down syndrome].
Taga T
Rinsho Ketsueki; 2020; 61(9):1382-1387. PubMed ID: 33162539
[TBL] [Abstract] [Full Text] [Related]
4. gata1/SP1 and miR-874 mediate enterovirus-71-induced apoptosis in a granzyme-B-dependent manner in Jurkat cells.
Zhang M; Chen Y; Cheng X; Cai Z; Qiu S
Arch Virol; 2020 Nov; 165(11):2531-2540. PubMed ID: 32851429
[TBL] [Abstract] [Full Text] [Related]
5. ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients.
Xie Y; Gao L; Xu C; Chu L; Gao L; Wu R; Liu Y; Liu T; Sun XJ; Ren R; Tang J; Zheng Y; Zhou Y; Shen S
Haematologica; 2020 Apr; 105(4):925-936. PubMed ID: 31467124
[TBL] [Abstract] [Full Text] [Related]
6. Compounds targeting class II histone deacetylases do not cause panHDACI-associated impairment of megakaryocyte differentiation.
Simic D; Sang N
Exp Hematol; 2019 Apr; 72():36-46. PubMed ID: 30611870
[TBL] [Abstract] [Full Text] [Related]
7. Ginsenoside F1 Promotes Cytotoxic Activity of NK Cells via Insulin-Like Growth Factor-1-Dependent Mechanism.
Kwon HJ; Lee H; Choi GE; Kwon SJ; Song AY; Kim SJ; Choi WS; Hwang SH; Kim SC; Kim HS
Front Immunol; 2018; 9():2785. PubMed ID: 30546365
[TBL] [Abstract] [Full Text] [Related]
8. Autophagy as a regulatory component of erythropoiesis.
Zhang J; Wu K; Xiao X; Liao J; Hu Q; Chen H; Liu J; An X
Int J Mol Sci; 2015 Feb; 16(2):4083-94. PubMed ID: 25689426
[TBL] [Abstract] [Full Text] [Related]
9. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
Tigay JH
J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
[TBL] [Abstract] [Full Text] [Related]
10. Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Xavier AC; Ge Y; Taub JW
J Mol Diagn; 2009 Sep; 11(5):371-80. PubMed ID: 19710397
[TBL] [Abstract] [Full Text] [Related]
11. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
[TBL] [Abstract] [Full Text] [Related]
12. [Oncogenes and leukemia: history and perspectives].
Gisselbrecht S
Med Sci (Paris); 2003 Feb; 19(2):201-10. PubMed ID: 12836614
[TBL] [Abstract] [Full Text] [Related]
13. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
[TBL] [Abstract] [Full Text] [Related]
